Bookmark
Explore Study in Browser
Study Report - GWAS of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C (HGVST374)
The following Sample Panels are defined in this Study. What is a Sample Panel
| Sample Panel name | No. individuals | Panel composition | Geographic region |
|---|---|---|---|
| Initial sample panel for HGVST374 | 154 | Not provided | Not provided |
| Replication sample panel for HGVST374 | 172 | Not provided | Not provided |
The following Assayed Panels are defined in this Study. What is an Assayed Panel
| Assayed Panel name | No. individuals | Selected from Sample Panel(s) | Phenotype(s) Tested |
|---|---|---|---|
| Japanese responders | 72 | Initial sample panel for HGVST374 |
|
| Japanese non-responders | 82 | Initial sample panel for HGVST374 |
|
| Japanese responders | 122 | Replication sample panel for HGVST374 |
|
| Japanese non-responders | 50 | Replication sample panel for HGVST374 |
|